He started on metformin and a couple of other medications, made lifestyle changes, and lost 20 pounds, improving his A1C (average blood sugar levels) from 10.5% to 7.2%
It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it acts on two different hormonal pathways to help regulate blood sugar levels and confer additional metabolic benefits, including weight loss
doi: 10.1038/s41438-020-00428-4 86 ShuP.LiY.XiangL.ShengJ.ShenL
CampbellSGeorgeDKRobbSDSpoonerRMcDonaghTADargieHJet alThe prevalence of haemochromatosis gene mutations in the west of Scotland and their relation to ischaemic heart disease
GLP-1 medications are intriguing from a cancer research perspective because they werent designed for cancer therapy, but they do affect many different targets and pathways associated with cancer development, so were eager to study them in this context, McDonald said
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
